Arbutus Biopharma Corporation (ABUS) NASDAQ

3.35

-0.06(-1.76%)

Updated at January 08 04:00PM

Currency In USD

Valuation

Market Cap414.9M
Enterprise Value397.34M
P/E Ratio-8.25
PEG Ratio-1.82
Price/Sales Ratio94.16
Price/Book Ratio5.92
Enterprise/Revenue89.65
Enterprise/EBITDA-8.04

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-11.38
Operating Margin-12.24

Management Effectiveness

Return On Assets-0.55
Return On Equity-0.68

Income Statement

Revenue18.14M
Revenue/Share0.04
Gross Profit-55.56M
EBITDA-70.99M
Net Income-72.85M
Diluted EPS-0.44

Balance Sheet

Total Cash127.79M
Total Cash/Share0.68
Total Debt1.45M
Total Debt/Equity0
Current Ratio7.02
Book Value Per Share0.57

Price History

52-Week Change37.86
52-Week High4.72
52-Week Low2.21
Moving Average 50 Days3.54
Moving Average 200 Days3.48

Statistics

Average Volume886,383
Shares Outstanding189.49M
% Held by Institutions53.32

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:5
Last Split DateNovember 04, 2010